BACKGROUND: A higher circulating vitamin D level is inversely associated with the risk of colorectal cancer, but the association with adenoma risk is less clear. AIMS: We examined the association between the circulating 25-hydroxyvitamin D(3) [25(OH)D(3)] concentration and colorectal adenoma in asymptomatic average-risk participants undergoing initial screening colonoscopy. METHODS: The study subjects were comprised of 143 cases of colorectal adenomas and 143 age- and gender-matched controls with normal colonoscopy among the 586 asymptomatic average-risk subjects (median age, 58 years; range, 50-73 years) who underwent first screening colonoscopy and measurement of the serum 25(OH)D(3) between December 2009 and April 2010, consistent with winter months of the region. RESULTS: The mean concentration of serum 25(OH)D(3) in the adenoma and control groups was 20.0 ± 11.0 ng/ml and 25.0 ± 20.0 ng/ml, respectively (P = 0.009). Using multivariate analysis, higher levels of 25(OH)D(3) were associated with a statistically significant decreased risk of colorectal adenoma after multivariable adjustment (highest vs. lowest quartile OR 0.38, 95% CI 0.18-0.80, P (trend) = 0.012). The inverse association of circulating 25(OH)D(3) with colorectal adenoma was stronger among the patients with proximal adenoma than that among the patients without proximal adenoma (highest vs. lowest quartile OR 0.29, 95% CI 0.13-0.66, P (trend) = 0.001). CONCLUSIONS: The present study suggests that high levels of circulating vitamin D are associated with a decreased risk of colorectal adenoma, and especially adenoma located in the proximal colon.
BACKGROUND: A higher circulating vitamin D level is inversely associated with the risk of colorectal cancer, but the association with adenoma risk is less clear. AIMS: We examined the association between the circulating 25-hydroxyvitamin D(3) [25(OH)D(3)] concentration and colorectal adenoma in asymptomatic average-risk participants undergoing initial screening colonoscopy. METHODS: The study subjects were comprised of 143 cases of colorectal adenomas and 143 age- and gender-matched controls with normal colonoscopy among the 586 asymptomatic average-risk subjects (median age, 58 years; range, 50-73 years) who underwent first screening colonoscopy and measurement of the serum 25(OH)D(3) between December 2009 and April 2010, consistent with winter months of the region. RESULTS: The mean concentration of serum 25(OH)D(3) in the adenoma and control groups was 20.0 ± 11.0 ng/ml and 25.0 ± 20.0 ng/ml, respectively (P = 0.009). Using multivariate analysis, higher levels of 25(OH)D(3) were associated with a statistically significant decreased risk of colorectal adenoma after multivariable adjustment (highest vs. lowest quartile OR 0.38, 95% CI 0.18-0.80, P (trend) = 0.012). The inverse association of circulating 25(OH)D(3) with colorectal adenoma was stronger among the patients with proximal adenoma than that among the patients without proximal adenoma (highest vs. lowest quartile OR 0.29, 95% CI 0.13-0.66, P (trend) = 0.001). CONCLUSIONS: The present study suggests that high levels of circulating vitamin D are associated with a decreased risk of colorectal adenoma, and especially adenoma located in the proximal colon.
Authors: Veronika Fedirko; Roberd M Bostick; Michael Goodman; W Dana Flanders; Myron D Gross Journal: Am J Epidemiol Date: 2010-07-22 Impact factor: 4.897
Authors: Edward D Gorham; Cedric F Garland; Frank C Garland; William B Grant; Sharif B Mohr; Martin Lipkin; Harold L Newmark; Edward Giovannucci; Melissa Wei; Michael F Holick Journal: Am J Prev Med Date: 2007-03 Impact factor: 5.043
Authors: Elizabeth T Jacobs; David S Alberts; Jose Benuzillo; Bruce W Hollis; Patricia A Thompson; María Elena Martínez Journal: J Steroid Biochem Mol Biol Date: 2007-01-12 Impact factor: 4.292
Authors: Alexandra E Connelly; Jessie Satia-Abouta; Christopher F Martin; Temitope O Keku; John T Woosley; P Kay Lund; Robert S Sandler Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-06 Impact factor: 4.254
Authors: Ulrike Peters; Richard B Hayes; Nilanjan Chatterjee; Wen Shao; Robert E Schoen; Paul Pinsky; Bruce W Hollis; Katherine A McGlynn Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-04 Impact factor: 4.254
Authors: Kana Wu; Diane Feskanich; Charles S Fuchs; Walter C Willett; Bruce W Hollis; Edward L Giovannucci Journal: J Natl Cancer Inst Date: 2007-07-10 Impact factor: 13.506
Authors: Lillias H Maguire; Mingyang Song; Lisa E Strate; Edward L Giovannucci; Andrew T Chan Journal: Clin Gastroenterol Hepatol Date: 2013-08-15 Impact factor: 11.382
Authors: Amy A Irving; Lori A Plum; William J Blaser; Madeline R Ford; Chao Weng; Linda Clipson; Hector F DeLuca; William F Dove Journal: J Nutr Date: 2014-12-24 Impact factor: 4.798
Authors: Kelly McDaniel; Robert Correa; Tianhao Zhou; Christopher Johnson; Heather Francis; Shannon Glaser; Julie Venter; Gianfranco Alpini; Fanyin Meng Journal: Ann Transl Med Date: 2013-04-01
Authors: Elizabeth A Hibler; Christine L Sardo Molmenti; Peter Lance; Peter W Jurutka; Elizabeth T Jacobs Journal: Cancer Causes Control Date: 2014-04-16 Impact factor: 2.506
Authors: Elizabeth T Jacobs; Elizabeth A Hibler; Peter Lance; Christine L Sardo; Peter W Jurutka Journal: Int J Cancer Date: 2013-07-11 Impact factor: 7.396
Authors: Fabio Pibiri; Rick A Kittles; Robert S Sandler; Temitope O Keku; Sonia S Kupfer; Rosa M Xicola; Xavier Llor; Nathan A Ellis Journal: Cancer Causes Control Date: 2014-02-23 Impact factor: 2.506